Sumary of CWRU researcher receives $1.2 million to identify biomarkers for improving MS diagnoses:
- Briggs, the principal investigator, will work in collaboration with colleagues at the Mayo Clinic and Duke University..
- Farren Briggs, Assistant Professor, Department of Population and Quantitative Health Sciences in the School of Medicine Related Stories MS is a chronic and progressive autoimmune disease that attacks the protective sheath covering the nerve cells in the brain and spinal cord..
- MS symptoms are highly variable and can include impaired muscular coordination, numbness, tremors, and severe fatigue, as well as impaired speech and blurred vision..
- To address the challenge posed by initial misdiagnosis, Briggs and his colleagues will identify blood serum biomarkers that accurately classify people with MS, compared to unaffected individuals and those with other rare demyelinating and inflammatory diseases…